Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study
Authors
Keywords
Bisphosphonates, Epidemiology, Hip fracture, Mortality, Osteoporosis, Refracture
Journal
OSTEOPOROSIS INTERNATIONAL
Volume 27, Issue 1, Pages 387-396
Publisher
Springer Nature
Online
2015-11-17
DOI
10.1007/s00198-015-3415-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Crosstalk between bone niche and immune system: Osteoimmunology signaling as a potential target for cancer treatment
- (2015) Carmen Criscitiello et al. CANCER TREATMENT REVIEWS
- Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis
- (2015) Dae Hyun Kim et al. PLoS One
- Literature review: The effects of teriparatide therapy at the hip in patients with osteoporosis
- (2014) Erik F. Eriksen et al. BONE
- Mortality After Hip Fracture in Austria 2008–2011
- (2014) Wolfgang Brozek et al. CALCIFIED TISSUE INTERNATIONAL
- Risk Analysis for Second Hip Fracture in Patients After Hip Fracture Surgery: A Nationwide Population-Based Study
- (2014) Shih-Hsun Shen et al. Journal of the American Medical Directors Association
- Treatment of post-menopausal osteoporosis: beyond bisphosphonates
- (2014) S. Ishtiaq et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Intravenous Treatment With Ibandronate Normalizes Bone Matrix Mineralization and Reduces Cortical Porosity After Two Years in Male Osteoporosis: A Paired Biopsy Study
- (2013) Barbara M Misof et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bisphosphonate use and subsequent hip fracture in South Korea
- (2013) Y.-K. Lee et al. OSTEOPOROSIS INTERNATIONAL
- Ibandronate increases the expression of the pro-apoptotic gene FAS by epigenetic mechanisms in tumor cells
- (2012) R. Thaler et al. BIOCHEMICAL PHARMACOLOGY
- Osteoporotic hip fractures: Bisphosphonates sales and observed turning point in trend. A population-based retrospective study
- (2012) Sandra Maria Alves et al. BONE
- Effects of Bone-Targeted Agents on Cancer Progression and Mortality
- (2012) R. Coleman et al. JNCI-Journal of the National Cancer Institute
- Bisphosphonate use and increased incidence of subtrochanteric fracture in South Korea: results from the National Claim Registry
- (2012) Y.-K. Lee et al. OSTEOPOROSIS INTERNATIONAL
- Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients—a nationwide register-based open cohort study
- (2012) L. Bondo et al. OSTEOPOROSIS INTERNATIONAL
- Osteoporosis Medication and Reduced Mortality Risk in Elderly Women and Men
- (2011) Jacqueline R. Center et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Healthy User and Related Biases in Observational Studies of Preventive Interventions: A Primer for Physicians
- (2011) William H. Shrank et al. JOURNAL OF GENERAL INTERNAL MEDICINE
- Bisphosphonates for post-menopausal osteoporosis: are they all the same?
- (2011) R. Rizzoli QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- The Role of Falls in Fracture Prediction
- (2011) Heike A. Bischoff-Ferrari Current Osteoporosis Reports
- Alternative Use of Bisphosphonate Therapy for Rheumatic Disease
- (2010) B. Le Goff et al. CURRENT PHARMACEUTICAL DESIGN
- Antifracture Efficacy of Currently Available Therapies for Postmenopausal Osteoporosis
- (2010) Jean-Yves Reginster DRUGS
- Epidemiology of hip fracture: Worldwide geographic variation
- (2010) DineshK Dhanwal et al. Indian Journal of Orthopaedics
- Age-specific incidence of first and second fractures of the hip
- (2010) T. M. Lawrence et al. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
- Effect of Osteoporosis Treatment on Mortality: A Meta-Analysis
- (2010) Mark J. Bolland et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Oral bisphosphonates are associated with reduced mortality after hip fracture
- (2010) L. A. Beaupre et al. OSTEOPOROSIS INTERNATIONAL
- Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study
- (2010) P. N. Sambrook et al. OSTEOPOROSIS INTERNATIONAL
- Epidemiology of hip fractures in Austria: evidence for a change in the secular trend
- (2010) H. P. Dimai et al. OSTEOPOROSIS INTERNATIONAL
- Atypical Subtrochanteric and Femoral Shaft Fractures and Possible Association with Bisphosphonates
- (2010) Jeri W. Nieves et al. Current Osteoporosis Reports
- Trends in hip fracture epidemiology in Australia: Possible impact of bisphosphonates and hormone replacement therapy
- (2009) A.A. Fisher et al. BONE
- Incidence and Mortality of Hip Fractures in the United States
- (2009) Carmen A. Brauer JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hip Fracture Patients at Risk of Second Hip Fracture: A Nationwide Population-Based Cohort Study of 169,145 Cases During 1977–2001
- (2009) Jesper Ryg et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Potential mediators of the mortality reduction with zoledronic acid after hip fracture
- (2009) Cathleen S Colón-Emeric et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
- (2009) Steven R. Cummings et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mortality following hip fracture: Trends and geographical variations over the last 40 years
- (2008) S. Haleem et al. INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED
- Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register-Based National Cohort Study
- (2008) Bo Abrahamsen et al. JOURNAL OF BONE AND MINERAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started